Jane Street’s AbbVie ABBV Stock Holding History

Jane Street’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$153M	Buy	705,700 +307,200	+77%	+$68.1M	0.02%	477
2025 Q4	$91.1M	Sell	398,500 -328,400	-45%	-$74.8M	0.01%	623
2025 Q3	$168M	Buy	726,900 +157,900	+28%	+$32.2M	0.03%	400
2025 Q2	$106M	Sell	569,000 -28,400	-5%	-$5.28M	0.02%	446
2025 Q1	$125M	Buy	597,400 +111,400	+23%	+$21.7M	0.03%	316
2024 Q4	$86.4M	Sell	486,000 -131,400	-21%	-$24.2M	0.02%	479
2024 Q3	$122M	Buy	617,400 +49,500	+9%	+$9.24M	0.03%	335
2024 Q2	$97.4M	Sell	567,900 -183,700	-24%	-$30.4M	0.02%	418
2024 Q1	$137M	Buy	751,600 +141,500	+23%	+$24.4M	0.03%	296
2023 Q4	$94.5M	Sell	610,100 -9,200	-1%	-$1.34M	0.02%	402
2023 Q3	$92.3M	Buy	619,300 +26,200	+4%	+$3.85M	0.03%	347
2023 Q2	$79.9M	Buy	593,100 +147,600	+33%	+$21.6M	0.03%	416
2023 Q1	$71M	Sell	445,500 -275,400	-38%	-$42.1M	0.03%	394
2022 Q4	$117M	Buy	720,900 +22,800	+3%	+$3.5M	0.05%	247
2022 Q3	$93.7M	Sell	698,100 -205,500	-23%	-$29.5M	0.04%	295
2022 Q2	$138M	Buy	903,600 +142,000	+19%	+$21.7M	0.06%	221
2022 Q1	$123M	Sell	761,600 -8,400	-1%	-$1.22M	0.04%	306
2021 Q4	$104M	Sell	770,000 -69,900	-8%	-$8.26M	0.03%	355
2021 Q3	$90.6M	Buy	839,900 +189,200	+29%	+$21.6M	0.03%	369
2021 Q2	$73.3M	Buy	650,700 +323,500	+99%	+$36.4M	0.03%	402
2021 Q1	$35.4M	Sell	327,200 -197,000	-38%	-$21.1M	0.02%	618
2020 Q4	$56.2M	Sell	524,200 -88,300	-14%	-$8.49M	0.03%	416
2020 Q3	$53.6M	Buy	612,500 +113,600	+23%	+$10.7M	0.03%	366
2020 Q2	$49M	Sell	498,900 -64,200	-11%	-$5.65M	0.04%	368
2020 Q1	$42.9M	Buy	563,100 +194,700	+53%	+$16.6M	0.04%	271
2019 Q4	$32.6M	Sell	368,400 -186,700	-34%	-$15.5M	0.05%	260
2019 Q3	$42M	Buy	555,100 +71,600	+15%	+$4.91M	0.07%	196
2019 Q2	$35.2M	Buy	483,500 +263,300	+120%	+$20.7M	0.06%	231
2019 Q1	$17.7M	Buy	220,200 +70,700	+47%	+$5.78M	0.03%	444
2018 Q4	$13.8M	Buy	149,500 +98,100	+191%	+$8.63M	0.03%	439
2018 Q3	$4.86M	Buy	51,400 +17,400	+51%	+$1.65M	0.01%	1060
2018 Q2	$3.15M	Sell	34,000 -91,900	-73%	-$8.98M	0.01%	1445
2018 Q1	$11.9M	Buy	125,900 +111,500	+774%	+$12.2M	0.03%	468
2017 Q4	$1.39M	Sell	14,400 -33,700	-70%	-$3.18M	﹤0.01%	1952
2017 Q3	$4.27M	Buy	48,100 +40,100	+501%	+$3.05M	0.01%	989
2017 Q2	$580K	Sell	8,000 -6,600	-45%	-$444K	﹤0.01%	2838
2017 Q1	$951K	Sell	14,600 -19,500	-57%	-$1.23M	﹤0.01%	2116
2016 Q4	$2.13M	Buy	34,100 +17,000	+99%	+$1.04M	0.01%	1261
2016 Q3	$1.08M	Sell	17,100 -24,500	-59%	-$1.59M	0.01%	1855
2016 Q2	$2.58M	Buy	41,600 +14,800	+55%	+$902K	0.01%	1044
2016 Q1	$1.53M	Buy	26,800 +13,800	+106%	+$769K	0.01%	1430
2015 Q4	$770K	Buy	13,000 +7,600	+141%	+$438K	﹤0.01%	2020
2015 Q3	$294K	Sell	5,400 -13,200	-71%	-$859K	﹤0.01%	2813
2015 Q2	$1.25M	Sell	18,600 -10,000	-35%	-$653K	0.01%	1366
2015 Q1	$1.67M	Buy	+28,600	New	+$1.73M	0.01%	997

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jane Street's ABBV Position: Q1 2026 in Review

Jane Street reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $2.75M and leaving 77,362 shares worth $16.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Jane Street first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $107M in Q2 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Jane Street held 77,362 shares of AbbVie worth $16.8M as of Q1 2026.
Jane Street sold 12,385 AbbVie shares in Q1 2026, an estimated $2.75M.
AbbVie made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1952 holding.
Jane Street first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
Jane Street's AbbVie position peaked at $107M in Q2 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.